Medical Weight Loss & GLP-1 Programs
Semaglutide vs Tirzepatide
Semaglutide and tirzepatide are the two most widely used GLP-1 weight-loss medications in concierge practice today. Both are once-weekly injections, both regulate appetite and gastric emptying, and both can produce meaningful sustained weight loss. The differences come down to mechanism, average outcomes, side-effect profile, and patient-specific fit. Here's how we think about choosing between them at Vivere Drip Therapy.
Mechanism — Single vs Dual Receptor
Semaglutide is a GLP-1 receptor agonist — it activates one receptor system. Tirzepatide activates two: GLP-1 plus GIP (glucose-dependent insulinotropic polypeptide). The dual receptor activity appears to produce stronger appetite suppression and greater metabolic effects in most patients, though the magnitude of difference varies individually.
Average Weight Loss
In published clinical trials, semaglutide at maximum dose produces average weight loss in the 12–15% range over a year. Tirzepatide at its highest dose has shown averages closer to 20–22% over a comparable timeframe. These are population averages — individual responses range widely in both directions on either medication.
Side-Effect Profile
Both medications share the same primary side-effect pattern: nausea, constipation, occasional reflux, and reduced appetite (which is, of course, partly the intended effect). Tolerability tends to be similar; some patients do better on one than the other, and switching is a reasonable strategy if the first medication causes ongoing issues. Slow titration is the most reliable side-effect mitigation for both.
How We Choose
Selection typically considers prior GLP-1 experience, response on previous attempts, comorbid conditions, insurance and cost considerations, and supply availability. For most patients starting fresh and seeking the strongest average result, tirzepatide is often the first consideration. For patients with cost constraints, those who tolerated semaglutide well in the past, or those wanting a longer track record, semaglutide remains an excellent choice.
Frequently Asked Questions
Can I switch from Semaglutide to Tirzepatide?
Yes — many patients transition between the two when response plateaus or side effects become limiting. The transition is managed by your provider with appropriate timing and re-titration of the new medication.
Is the cost difference significant?
Tirzepatide is generally more expensive than semaglutide, though pricing varies by formulation, dose, and supply. Your program quote will reflect current pricing for the medication that fits your protocol.
These therapies are offered as part of individualized medical weight-loss programs supervised by a licensed clinician and are not a substitute for evaluation of underlying medical conditions. Suitability, dosing, and program structure are determined by your provider based on your full health history. Information provided here is educational, not medical advice.
Related Topics
Book a Consultation
Every weight-loss program at Vivere is individualized. Book a consultation at our Carmel or Salinas clinic — or via telehealth from anywhere in the U.S. — to learn whether GLP-1 therapy is the right next step for you.